Calithera Biosciences Stock Forecast NASDAQ:CALA

Price Target and Analyst Ratings

Most Recent Rating

On August 09, 2021 "HC Wainwright" gave "$4.00" rating for CALA. The price target was changed from $2.18 to 5.2%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-09	$4.00	Reiterated by	HC Wainwright	$2.22	$2.18→5.2%
2021-05-10	Buy	Reiterated by	HC Wainwright	$1.96	$4.00
2021-01-05		Target Lowered by	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	$2.70	$10.00 → $5.00
2021-01-05		Target Lowered by	Smith Barney Citigroup	$2.70	$10.00 → $5.00
2021-01-05	Buy	Target Lowered by	HC Wainwright	$2.70	$9.50 → $4.00
2021-01-05	Market Perform	Downgraded by	SVB Leerink	$2.70	$7.00 → $2.00
2020-08-11	Outperform	Target Lowered by	SVB Leerink	$4.16	$9.00 → $7.00
2020-06-02	Buy	Reiterated by	William Blair	$5.71
2020-05-11	Buy	Target Raised by	Citigroup	$6.84	$7.00 → $10.00
2020-05-08	Buy	Reiterated by	HC Wainwright	$6.65	$7.00 → $9.50

CALA Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 17.07% during the next 3 months and, with a 90% probability hold a price between $2.47 and $3.00 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-30	$2.12	$2.34	$2.57
2021-10-01	$2.12	$2.35	$2.57
2021-10-04	$2.13	$2.35	$2.58
2021-10-05	$2.13	$2.36	$2.59
2021-10-06	$2.14	$2.37	$2.59
2021-10-07	$2.14	$2.37	$2.60
2021-10-08	$2.15	$2.38	$2.60
2021-10-11	$2.16	$2.38	$2.61
2021-10-12	$2.16	$2.39	$2.62
2021-10-13	$2.17	$2.40	$2.62
2021-10-14	$2.17	$2.40	$2.63
2021-10-15	$2.18	$2.41	$2.63
2021-10-18	$2.19	$2.41	$2.64
2021-10-19	$2.19	$2.42	$2.65
2021-10-20	$2.20	$2.42	$2.65
2021-10-21	$2.20	$2.43	$2.66
2021-10-22	$2.21	$2.44	$2.66
2021-10-25	$2.22	$2.44	$2.67
2021-10-26	$2.22	$2.45	$2.68
2021-10-27	$2.23	$2.45	$2.68
2021-10-28	$2.23	$2.46	$2.69
2021-10-29	$2.24	$2.47	$2.69
2021-11-01	$2.25	$2.47	$2.70
2021-11-02	$2.25	$2.48	$2.71
2021-11-03	$2.26	$2.48	$2.71
2021-11-04	$2.26	$2.49	$2.72
2021-11-05	$2.27	$2.50	$2.72
2021-11-08	$2.28	$2.50	$2.73
2021-11-09	$2.28	$2.51	$2.73
2021-11-10	$2.29	$2.51	$2.74

About Calithera Biosciences

Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myelom... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!